ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q4 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,936 | -18.9% | 21,830 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $19,640 | +11.4% | 21,830 | +84.5% | 0.00% | 0.0% |
| Q1 2022 | $17,627 | -34.6% | 11,830 | -4.8% | 0.00% | 0.0% |
| Q4 2021 | $26,973 | -39.3% | 12,430 | -0.4% | 0.00% | -50.0% |
| Q3 2021 | $44,429 | -38.0% | 12,480 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $71,635 | +10.6% | 12,480 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $64,771 | +4416.8% | 12,480 | +1980.0% | 0.00% | – |
| Q4 2020 | $1,434 | +57.6% | 600 | -8.4% | 0.00% | – |
| Q3 2020 | $910 | -83.3% | 655 | -77.1% | 0.00% | – |
| Q2 2020 | $5,453 | -22.0% | 2,855 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $6,995 | +129.4% | 2,855 | +110.7% | 0.00% | – |
| Q4 2019 | $3,049 | +7.1% | 1,355 | 0.0% | 0.00% | – |
| Q3 2019 | $2,846 | – | 1,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |